Dr Rubina Mian

Founder & CEO, OzMian Ltd.

Dr. Rubina Mian has led research teams in diverse sectors, including an international pharmaceutical company and academia. She has also served as a Non-Executive Director in the NHS. She pioneered a groundbreaking platform technology that involves a 10-minute fingertip test designed to unravel immune cell communication by decoding neutrophil signals. This innovative approach revolutionises personalised medicine, enabling powerful personalised disease tracking in real-time. Her invention is radically different from existing technologies as it is completely mobile, allowing access without the need for expensive hospital or lab-based procedures. It is a world first, as recognised by internationally granted patents.

Key Links

Millions of years of Evolution and Neutrophils are Nature’s own Bio-detectors

Neutrophils, as nature's bio detectors, play a crucial role in unraveling cross-cell communication and decoding how diseases spread. Dr Mian unravels the cell secrets by decoding cell signals in real time.

Ground breaking 10 minute finger-tip test from single drop blood

Dr. Rubina Mian is renowned for her groundbreaking inventions, including the development of a 10-minute fingertip test that enables rapid detection of serious life-threatening diseases by monitoring neutrophil function in whole fingertip blood.

International Patents

This innovative test, requiring only a drop of blood, has received international patents and has demonstrated successful applications in the early diagnosis of sepsis and cancer, advancing the field of rapid disease detection.

Blue Chip Companies

Dr. Rubina Mian's groundbreaking endeavors have sparked dynamic and interactive partnerships between academia and industry, encompassing blue chip companies such as Jaguar and Formula 1 Racing, premier league football clubs, and pharmaceutical giants. Moreover, her influential role as a Non-Executive Director of an NHS Trust has been instrumental in shaping strategic vision and propelling healthcare advancements.

Life threatening diseases

Her extensive expertise and inventive contributions have been instrumental in driving advancements rapid detection of serious life-threatening diseases including early detection on of metastatic cancer in over 25 different types of cancer and sepsis, with publications about her test being published in such journals as: